Nemaura Medical Inc. (NMRD)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jan 16, 2026, 4:00 PM EST
Nemaura Medical Market Cap
Nemaura Medical has a market cap or net worth of $40 as of January 20, 2026. Its market cap has decreased by -100.00% in one year.
Market Cap
40.00
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since December 18, 2014, Nemaura Medical's market cap has decreased from 50.00M to 40.00, a decrease of -100.00%. That is a compound annual growth rate of -71.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 40.00 | -99.01% |
| Dec 31, 2024 | 4.04K | -99.94% |
| Dec 29, 2023 | 6.33M | -84.71% |
| Dec 30, 2022 | 41.39M | -61.06% |
| Dec 31, 2021 | 106.28M | 23.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 782.06M |
| Glass House Brands | 715.55M |
| Elite Pharmaceuticals | 505.65M |
| Northwest Biotherapeutics | 472.88M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.20M |
| CytoDyn | 328.21M |
| Silence Therapeutics | 238.06M |